Location History:
- King of Prussia, PA (US) (2002 - 2010)
- Philadelphia, PA (US) (2018)
- Bryn Mawr, PA (US) (1996 - 2019)
Company Filing History:
18 out of 20 
13 out of 80 
3 out of 35 
Years Active: 1996-2019
Areas of Expertise:
Title: H William Bosch: Innovating Pharmaceutical Formulations
Introduction
H William Bosch, based in Bryn Mawr, PA, is a prolific inventor with a remarkable portfolio of 41 patents. His work primarily focuses on innovative pharmaceutical formulations, contributing significantly to advancements in drug delivery and treatment methodologies.
Latest Patents
Among his latest patents is the formulation for Abiraterone, a nanoparticulate composition of abiraterone acetate. This formulation allows for treatment at a lower dose compared to conventional abiraterone acetate formulations, enhancing the method of treating prostate cancer by combining the composition with a glucocorticoid. Another notable patent relates to the formulation of indomethacin, detailing methods for producing particles of indomethacin through dry milling processes. This invention includes compositions comprising indomethacin, medicaments derived from it, and therapeutic methods for administering indomethacin in particulate form.
Career Highlights
H William Bosch has had an extensive career in the pharmaceutical industry, marked by his tenure at Iceutica Pty Ltd. and Elan Pharma International Limited. His innovative approach has fueled the development of essential formulations that address critical healthcare needs.
Collaborations
Throughout his career, Bosch has collaborated with notable professionals including Marck Norret and Felix Meiser. These partnerships have leveraged diverse expertise, enhancing the quality and impact of his pharmaceutical inventions.
Conclusion
H William Bosch stands out as an exemplary figure in the realm of pharmaceutical innovation. His 41 patents reflect a commitment to improving drug efficacy and patient outcomes through advanced formulations. As he continues his work, Bosch's contributions promise to influence the future of pharmaceutical sciences profoundly.